@article{100986,
  keywords = {Covid-19, Developing countries, Funding, Global health, Infectious Diseases, Neglected Tropical Diseases, One Health, Trypanosomiasis},
  author = {Kasozi K and MacLeod E and Welburn S},
  title = {One Health policy for combatting African trypanocide resistance.},
  abstract = {<p>The rise of African trypanocide resistance (ATr) is influenced by various factors such as evolutionary changes in the pathogen, the presence of resistance genes in the population, poor policy decisions, limited private-public partnerships to engage local communities, and insufficient funding for the development of new drugs over the past sixty years. These challenges have been exacerbated by the inadequate implementation of drug liberalization policies in the mid 20th century, leading to poor pharmacovigilance practices for veterinary drugs in low and middle income countries (LMICs). One health (OH), a disease management framework, provides practical solutions for addressing ATr, drawing on its success in managing previous epidemics like avian influenza in 2004 and the recent COVID-19 pandemic, where institutional collaborations were rapidly established. To combat ATr, OH initiatives involving both international and local partners at the policy and grassroots levels are crucial to generate community interest. The importance of political commitment, media involvement, and nongovernmental organizations cannot be overstated, as they are essential for resource mobilization and long-term sustainability in LMICs.</p>},
  year = {2024},
  journal = {One Health},
  volume = {19},
  pages = {1-5},
  month = {12/2024},
  issn = {2352-7714},
  url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11367463/pdf/main.pdf},
  doi = {10.1016/j.onehlt.2024.100871},
  language = {ENG},
}